rs371390356
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_006567.5(FARS2):c.754G>A(p.Ala252Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000102 in 1,597,432 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A252P) has been classified as Uncertain significance.
Frequency
Consequence
NM_006567.5 missense
Scores
Clinical Significance
Conservation
Publications
- metabolic diseaseInheritance: AR Classification: DEFINITIVE Submitted by: G2P
- combined oxidative phosphorylation defect type 14Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- hereditary spastic paraplegia 77Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Leigh syndromeInheritance: AR Classification: MODERATE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FARS2 | ENST00000274680.9 | c.754G>A | p.Ala252Thr | missense_variant | Exon 3 of 7 | 1 | NM_006567.5 | ENSP00000274680.4 | ||
| FARS2 | ENST00000324331.10 | c.754G>A | p.Ala252Thr | missense_variant | Exon 3 of 7 | 1 | ENSP00000316335.5 | |||
| FARS2 | ENST00000445533.1 | c.142G>A | p.Ala48Thr | missense_variant | Exon 1 of 3 | 3 | ENSP00000392525.1 | |||
| FARS2 | ENST00000648580.1 | n.754G>A | non_coding_transcript_exon_variant | Exon 3 of 9 | ENSP00000497889.1 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 151982Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000163 AC: 4AN: 245304 AF XY: 0.0000151 show subpopulations
GnomAD4 exome AF: 0.000109 AC: 157AN: 1445450Hom.: 0 Cov.: 31 AF XY: 0.000109 AC XY: 78AN XY: 718380 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000395 AC: 6AN: 151982Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74228 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Combined oxidative phosphorylation defect type 14 Uncertain:1
This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 252 of the FARS2 protein (p.Ala252Thr). This variant is present in population databases (rs371390356, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with FARS2-related conditions. ClinVar contains an entry for this variant (Variation ID: 473316). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt FARS2 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at